Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Davis

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Epilepsy & Behavior : E&B|July 11, 2022
Quality-of-life results in adults with epilepsy using diazepam nasal spray for seizure clusters from a long-term, open-label safety studyJoyce A Cramer, Edward Faught, Charles Davis, et al.
Epilepsy & Behavior : E&B|August 24, 2024
Treatment of prolonged seizure with diazepam nasal spray: An exploratory post hoc cohort analysisRanda Jarrar, John M Stern, Danielle A Becker, et al.
Journal of Pharmaceutical Sciences|September 7, 2004
Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activityLai-Xi Wang, Alonso Heredia, Haijing Song, et al.
AIDS (London, England)|May 4, 2005
In vitro suppression of latent HIV-1 activation by vitamin E: potential clinical implicationsAlonso Heredia, Charles Davis, Anthony Amoroso, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|July 3, 2018
Dextromethorphan/Quinidine for Pseudobulbar Affect Following Stroke: Safety and Effectiveness in the PRISM II TrialRichard D Zorowitz, David N Alexander, Andrea E Formella, et al.
Trials|June 13, 2019
Oleogel-S10 Phase 3 study "EASE" for epidermolysis bullosa: study design and rationaleJohannes S Kern, Agnes Schwieger-Briel, Sandra Löwe, et al.
The New Phytologist|June 15, 2026
The digital biodiversity revolutionAlexandre Antonelli, Charles Davis, Isabel Larridon, et al.
Cephalalgia : an International Journal of Headache|September 22, 2010
Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trialMichel D Ferrari, Markus Färkkilä, Uwe Reuter, et al.
The Journal of Bone and Joint Surgery. American Volume|January 6, 2012
Impact of comorbidities on hospitalization costs following hip fractureLucas E Nikkel, Edward J Fox, Kevin P Black, et al.
Journal of Orthopaedic Trauma|November 10, 2011
Locking plates in osteoporosis: a biomechanical cadaveric study of diaphyseal humerus fracturesCharles Davis, Alec Stall, Elisa Knutsen, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Epilepsy & Behavior : E&B|July 11, 2022
Quality-of-life results in adults with epilepsy using diazepam nasal spray for seizure clusters from a long-term, open-label safety studyJoyce A Cramer, Edward Faught, Charles Davis, et al.
Epilepsy & Behavior : E&B|August 24, 2024
Treatment of prolonged seizure with diazepam nasal spray: An exploratory post hoc cohort analysisRanda Jarrar, John M Stern, Danielle A Becker, et al.
Journal of Pharmaceutical Sciences|September 7, 2004
Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activityLai-Xi Wang, Alonso Heredia, Haijing Song, et al.
AIDS (London, England)|May 4, 2005
In vitro suppression of latent HIV-1 activation by vitamin E: potential clinical implicationsAlonso Heredia, Charles Davis, Anthony Amoroso, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|July 3, 2018
Dextromethorphan/Quinidine for Pseudobulbar Affect Following Stroke: Safety and Effectiveness in the PRISM II TrialRichard D Zorowitz, David N Alexander, Andrea E Formella, et al.
Trials|June 13, 2019
Oleogel-S10 Phase 3 study "EASE" for epidermolysis bullosa: study design and rationaleJohannes S Kern, Agnes Schwieger-Briel, Sandra Löwe, et al.
The New Phytologist|June 15, 2026
The digital biodiversity revolutionAlexandre Antonelli, Charles Davis, Isabel Larridon, et al.
Cephalalgia : an International Journal of Headache|September 22, 2010
Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trialMichel D Ferrari, Markus Färkkilä, Uwe Reuter, et al.
The Journal of Bone and Joint Surgery. American Volume|January 6, 2012
Impact of comorbidities on hospitalization costs following hip fractureLucas E Nikkel, Edward J Fox, Kevin P Black, et al.
Journal of Orthopaedic Trauma|November 10, 2011
Locking plates in osteoporosis: a biomechanical cadaveric study of diaphyseal humerus fracturesCharles Davis, Alec Stall, Elisa Knutsen, et al.
Pageof 11